IMTXSMALL

Immatics N.V.

HealthcareBiotechnology
$11.14
$0.00(-3.21%)
52W$4.06
$12.41
Updated May 8, 12:00 AM
RSI61
RS Rating78/99
Beta1.63
Volatility66%
F-Score6/9
Mkt Cap$1.5B
STAGE 2 UPTREND

Price Action

5Y Daily
50 DMA150 DMA200 DMA

Technical Summary

STAGE 2 UPTREND

Immatics N.V. is in a confirmed Stage 2 uptrend, with price holding above all major moving averages and trend structure remaining intact. Relative strength is moderate (RS Rating: 78), indicating performance broadly in line with the market. Earnings contraction of 282% provides fundamental context to the price action. Investors should exercise caution due to high volatility (66% annualized), which requires wider risk management.

Relative Strength
78
out of 99
Average
Trend Score
4/4
Minervini Criteria
STAGE 2 UPTREND
Risk (Beta)
1.63
vs S&P 500
HIGH BETA
52W Position
85%
from 52W low
Near High
Trend & Momentum Analysis

Trend Template (Minervini)

STAGE 2 UPTREND4/4 Criteria Met
CriterionValueStatus
Price > 50 SMA$10.38
50 SMA > 100 SMA$10.14
100 SMA > 150 SMA$10.13
150 SMA > 200 SMA$9.17

Price vs Moving Averages

PeriodValueSpreadSignal
20 SMA$11.11+0.30%ABOVE
50 SMA$10.38+7.30%ABOVE
100 SMA$10.14+9.89%ABOVE
150 SMA$10.13+10.02%ABOVE
200 SMA$9.17+21.49%ABOVE

Price Performance

1D-3.2%
1W+1.4%
1M+8.7%
3M+8.2%
6M+23.1%
YTD+6.6%
1Y+153.8%
3Y+4.3%
52-Week Trading Range85% from low
$11.14
52W Low$4.06
52W High$12.41

Technical Indicators

RSI (14)BULLISH
60.9
305070
VCP ScoreCOOL
5/10
Base depth: 22.8%

Risk Profile

Beta
1.63
52W Vol
66%
ATR
$0.40
Max DD (1Y)
-28%

Volume Analysis

Today
556.3K
50D Avg
449.0K
Vol Ratio
1.24x
Liquidity
ILLIQUID

Earnings Momentum

Q4'24+248%
$0.46
Q1'25-961%
$-0.33
Q2'25-241%
$-0.58
Q3'25-282%
$-0.42
Fundamentals & Growth

Growth Trends

Compounded Sales Growth

10 Years:
5 Years:+53.23%
3 Years:+64.89%
TTM:-26.73%

Compounded Profit Growth

10 Years:
5 Years:
3 Years:
TTM:-40.07%

Stock Price CAGR

10 Years:+1.50%
5 Years:-0.67%
3 Years:+4.26%
1 Year:+153.76%

Return on Equity

10Y Avg:-176.1%
5Y Avg:-176.1%
3Y Avg:-2.9%
Last Year:-27.8%

Key Metrics

Market Cap$1.5B
Gross Margin1.0%
Net Margin9.8%
Piotroski F-Score6/9

Frequently Asked Questions

Is IMTX in an uptrend right now?

IMTX has a trend score of 4/4 based on Minervini's Stage Analysis. Yes, IMTX is in a Stage 2 uptrend with price above all major moving averages (50, 100, 150, 200 SMA) properly stacked.

Is IMTX overbought or oversold?

IMTX's RSI (14) is 61. The stock is in neutral territory, neither overbought nor oversold.

Is IMTX outperforming the market?

IMTX has a Relative Strength (RS) Rating of 78 out of 99. IMTX is performing about average compared to the market.

Where is IMTX in its 52-week range?

IMTX is trading at $11.14, which is 90% of its 52-week high ($12.41) and 85% above its 52-week low ($4.06).

How volatile is IMTX?

IMTX has a Beta of 1.63 and 52-week volatility of 66%. It's more volatile than the S&P 500 - expect bigger swings.

Disclaimer: Data is for informational purposes only. May be delayed or contain errors. Past performance does not guarantee future results. This is not financial advice. Always conduct your own research and consult professionals before making investment decisions.